新型抗菌剂对肺炎菌株的体外抗菌活性和潜在的耐药机制:一个多中心研究
Zichen Lei1,2,3, Qi Liu1,2, Yiqun Ma2,4
1China-Japan Friendship Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
BMC microbiology
|April 28, 2025
概括
肺炎链球菌在中国表现出对常见抗生素的高耐药性. 新的抗微生物药物证明了对这些耐药菌株的有效性,提供了潜在的治疗解决方案.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 肺炎链球菌 (Streptococcus pneumoniae) 导致全球显著的死亡率,特别是在弱势群体中.
- 增加对青素,化物和诺基诺的抗生素耐药性使治疗复杂化.
- 关于新型抗菌剂对S. pneumoniae的耐药性模式的数据有限.
研究的目的:
- 调查中国S. pneumoniae分离物的分子特征和抗生素耐药性概况.
- 评估S. pneumoniae对新开发的抗菌剂的敏感性.
- 了解血清型,耐药机制和S. pneumoniae.病毒性之间的关系.
主要方法:
- 来自九家中国医院 (2023年1月至2024年6月) 的208个S. pneumoniae分离物的全基因组测序.
- 确定血清型,序列类型,病毒性基因和耐药性机制.
- 对14种药物进行抗生素敏感性测试,包括埃拉瓦环素,奥马环素,尼莫诺素和孔特佐利德.
主要成果:
- 血清型19F和23F占主导地位;PCV13覆盖率为66.8%.
- 对红红素 (100%),克林达胺素 (94.7%) 和四环素 (92.3%) 观察到高耐药率.
- 新型抗生素的耐药性较低:埃拉瓦环素 (1.9%),奥马环素 (0.5%),孔特佐利德 (1.9%) 和尼莫诺素 (7.2%).
结论:
- 在中国的S. pneumoniae表现出高度的遗传多样性和相当大的抗生素耐药性.
- 持续监测和更新的疫苗对于疾病管理至关重要.
- 新型抗生素对抗多药耐药性S.肺炎是有效的,提供了可行的临床选择.
关键词:
肺炎链球菌的肺炎链球菌.在Contezolid中使用.时代是埃瓦环素的时代尼莫诺克萨辛 (Nemonoxacin) 是一种一种新的抗生素 新的抗生素奥马达环素的使用方法电阻 电阻 电阻 电阻 电阻 电阻更多相关视频
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
13.4K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.5K
相关概念视频
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
